To ask the Secretary of State for the Home Department, what discussions she has had with (a) Cabinet colleagues and (b) the devolved administrations on making cannabis available through pharmaceuticals where use of that drug can be helpful. (8282)
Tabled on: 04 September 2017
Cannabis, in its raw form, has no recognised medicinal benefits in the UK.
There is a clear regime in place, administered by the Medicines and Healthcare products Regulatory Agency (MHRA), to enable medicines (including those containing controlled drugs such as cannabis) to be developed, licensed and made available for medicinal use to patients in the UK.
The Minister for Safeguarding, Vulnerability and Crime has recently written to and met with the Parliamentary under Secretary of State for Public Health and Primary Care to consider how to ensure cannabis-based medicines are available where appropriate.
Minister of State, Baroness Williams wrote to her counterpart Lord O’Shaughnessy on the same issue earlier in September.
Officials in the Home Office remain in frequent dialogue with officials of the devolved administrations on all aspects of drug policy.
The answer was submitted on 20 Sep 2017 at 14:18.